article thumbnail

BCG-OPPI report: Winning in the Indian healthcare market to unlock disruptive growth

Express Pharma

India’s pharmaceutical market, currently valued at approximately $60 billion, is projected to double by 2030. Getting this right will hold the key to winning a disproportionate market share in a large and expanding value pool (~$12B domestic market for global pharma companies by 2030).

article thumbnail

AstraZeneca announces $50bn US investment plans by 2030

Pharmaceutical Technology

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The focus of the investment is a manufacturing facility dedicated to producing drug substances for AstraZeneca.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Startups: India’s next big bet on pharma innovation?

Express Pharma

Singh attributes this decline to a mix of global and local challenges, “The slowdown is likely driven by a mix of global pricing pressures, regulatory shifts, and changing export dynamics, including stricter scrutiny of pharmaceutical exports from India and adjustments in domestic drug pricing policies.”

article thumbnail

Evaluate Issues Annual World Preview Report

Pharmaceutical Commerce

Image Credit: Adobe Stock Images/StockMediaLabs.com Evaluate, who provides market insights for the pharma industry, has unveiled its “2025 World Preview Report,” which offers insights for the global pharmaceutical market through the year 2030. They are also expected make up close to 9% of all Rx drug sales by the end of the decade.

article thumbnail

Alliance for impact – advancing CGT development in Europe

European Pharmaceutical Review

This includes initiatives such as ATMP 2030 led out of Sweden. While there may be economy in scale, the challenge is to model how new drugs on the market will be valued. There needs to be balance, especially for a global marketing strategy where drug prices are historically higher in regions such as the US to that of Europe.

article thumbnail

As Trump Pharma Tariff Deadline Looms, Here's How the Sector Got Here

Pharmaceutical Commerce

Tariffs on China will make generic drug prices go up I assume because China is such an important supplier of active pharmaceutical ingredients, as well as finished products.” 13 The president believes that that the order could help decrease drug prices by 30% to 80%. Pharmaceutical Commerce. February 5, 2025. Saraceno N.

article thumbnail

United States, European Union Reach Trade Pact

Pharmaceutical Commerce

The tariff is meant to encourage pharma manufacturers to reshore their production back to the United States, which has been in the works for many players, including AstraZeneca, who plans to invest $50 billion by 2030 in US-based drug manufacturing and R&D, marking its largest single manufacturing investment globally.